Vaxart, Inc. insiders have been one-way buyers this past year: two people put roughly $31,000 into the stock and nobody sold with their own money.
The largest purchase came from HERON ELAINE J (Director), about $9,055.
No open-market insider buying or selling in the last full quarter. Insiders bought in 4 of the last 7 full quarters. Big money check: 4 institutions held VXRT as of Q2 2026, and more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | Watson W. Mark | Director | Buy | 10,000 | $0.65 | $6K | SEC |
| Dec 5, 2025 | Watson W. Mark | Director | Buy | 15,000 | $0.41 | $6K | SEC |
| Dec 5, 2025 | Watson W. Mark | Director | Buy | 5,000 | $0.41 | $2K | SEC |
| Nov 21, 2025 | HERON ELAINE J | Director | Buy | 23,217 | $0.39 | $9K | SEC |
| Nov 21, 2025 | HERON ELAINE J | Director | Buy | 16,783 | $0.41 | $7K | SEC |
| Aug 19, 2025 | Finney Kevin | Director | Buy | 25,874 | $0.38 | $10K | SEC |
| Aug 19, 2025 | Finney Kevin | Director | Buy | 20,000 | $0.40 | $8K | SEC |
| Aug 19, 2025 | Finney Kevin | Director | Buy | 794 | $0.38 | $302 | SEC |
| Aug 19, 2025 | Finney Kevin | Director | Buy | 20,000 | $0.39 | $8K | SEC |
| Aug 19, 2025 | Finney Kevin | Director | Buy | 50,000 | $0.35 | $18K | SEC |
| Aug 19, 2025 | Finney Kevin | Director | Buy | 50,000 | $0.37 | $18K | SEC |
| Jul 31, 2025 | Watson W. Mark | Director | Buy | 10,000 | $0.41 | $4K | SEC |
| May 19, 2025 | Lo Steven | President | Buy | 100,000 | $0.49 | $49K | SEC |
| Jun 20, 2024 | Watson W. Mark | Director | Buy | 20,000 | $0.68 | $14K | SEC |
In the last 12 months Vaxart, Inc. insiders made open-market purchases worth about $31,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in VXRT was filed on 2026-05-26.
4 investment managers reported holding VXRT in SEC Form 13F filings for Q2 2026.
No congressional trades in VXRT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).